Edison signs deployment deal with Pfizer: Kosmos agent to work inside oncology, internal medicine and immunology R&D data
Edison Scientific announced an agreement to deploy the Edison AI Platform and its AI scientist Kosmos across Pfizer's biopharmaceutical R&D pipeline. Kosmos will access Pfizer's data in oncology, internal medicine, immunology and other areas to support Pfizer's scientists, inform critical R&D decisions and help accelerate discovery of potential new medicines. At the core is Kosmos's continuous learning, which combines public and Pfizer proprietary drug-development data into integrated world models, while Edison's forward-deployed scientists and engineers build Kosmos into specific workflows alongside Pfizer research teams.